Author

D. Fantini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. P. Glaser· 2 shared J. J. Meeks· 2 shared A. Iyer· 1 shared A. Kohn-Luque· 1 shared D. Baker· 1 shared D. Sengupta· 1 shared E. T. Courtois· 1 shared G. M. Malandsmo· 1 shared

Activity by Year

2017-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. P. Glaser

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression

S. Ghannoum, D. Fantini, M. Zahoor, V. R. Farhan, S. Phuyal, W. L. Netto, O. Sorensen, A. Iyer, D. Sengupta, L. Prasmickaite, G. M. Malandsmo, A. Kohn-Luque, H. Farhan

The paper develops a computational model to study cell migration traits in tumor progression and finds that Giantin depletion increases intravasation, validated by lower Giantin levels in circulating tumor cells.

bioRxiv · Apr 25, 2022Cancer Biology

Antibody Targeting of B7-H4 Enhances the Immune Response in Urothelial Carcinoma

J. R. Podojil, A. P. Glaser, D. Baker, E. T. Courtois, D. Fantini, Y. Yu, V. Eaton, S. Sivajothi, P. Robson, S. Miller, J. J. Meeks

This study identifies B7-H4 as a potential therapeutic target in bladder cancer, showing that anti-B7-H4 antibodies enhance immune responses and reduce tumor size in preclinical models.

bioRxiv · Aug 10, 2019Cancer Biology

APOBEC-Mediated Mutagenesis In Urothelial Carcinoma Is Associated With Improved Survival, Mutations In DNA Damage Response Genes, And Immune Response

A. P. Glaser, D. Fantini, K. J. Rimar, J. J. Meeks

The paper examines APOBEC-mediated mutagenesis in bladder cancer, finding it correlates with improved survival, mutations in DNA damage response genes, and immune response activation.

bioRxiv · Apr 4, 2017Cancer Biology